Clobetasol 0.05% spray in patients with moderate-to-severe plaque psoriasis

Trial Profile

Clobetasol 0.05% spray in patients with moderate-to-severe plaque psoriasis

Completed
Phase of Trial: Phase III

Latest Information Update: 06 Apr 2012

At a glance

  • Drugs Clobetasol (Primary)
  • Indications Plaque psoriasis
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Apr 2012 New trial record
    • 20 Mar 2012 Results reporting the effects of treatment on plaque psoriasis signs presented at the 70th Annual Meeting of the American Academy of Dermatology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top